We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Avacta Announces Distribution Agreement With ABCAM plc

Product News   Apr 08, 2021

 
Avacta Announces Distribution Agreement With ABCAM plc

Credit: Shaun F/ Pixabay

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

UK Diagnostic Company Collaborates With UK COV-AD Trial

Product News

Oxford Immunotec has announced that its T-SPOT®.COVID test will be used for T cell testing in the COV-AD (COVID infection in patients with Antibody Deficiency) study in collaboration with the University of Birmingham.

READ MORE

Phico Therapeutics Raises £7 million Investment

Product News

Phico Therapeutics Ltd has announced £7 million in new investment. The financing was led by the UK’s most active growth capital investor, BGF which invested £3 million and was joined by other existing Phico investors.

READ MORE

FDA Approves Orgenesis IDE for Pilot Clinical Trial of its Tissue Genesis Icellator2(R)

Product News

Orgenesis Inc. announces it has been granted Investigational Device Exemption (IDE) approval by the United States Food and Drug Administration (FDA) to conduct a first-in-human feasibility study of the Tissue Genesis Icellator2(R) to treat Acute Respiratory Distress Syndrome (ARDS) resulting from COVID-19 infection.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE